These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 39029483)
21. Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial. Alistar A; Morris BB; Desnoyer R; Klepin HD; Hosseinzadeh K; Clark C; Cameron A; Leyendecker J; D'Agostino R; Topaloglu U; Boteju LW; Boteju AR; Shorr R; Zachar Z; Bingham PM; Ahmed T; Crane S; Shah R; Migliano JJ; Pardee TS; Miller L; Hawkins G; Jin G; Zhang W; Pasche B Lancet Oncol; 2017 Jun; 18(6):770-778. PubMed ID: 28495639 [TBL] [Abstract][Full Text] [Related]
22. MR-guided neurolytic celiac plexus ablation: an evaluation of effect and injection spread pattern in cancer patients with celiac tumor infiltration. Akural E; Ojala RO; Järvimäki V; Kariniemi J; Tervonen OA; Blanco Sequeiros R Cardiovasc Intervent Radiol; 2013 Apr; 36(2):472-8. PubMed ID: 22588275 [TBL] [Abstract][Full Text] [Related]
23. Endoscopic ultrasound-guided celiac plexus neurolysis in patients with unresectable pancreatic cancer. Ramirez-Luna MA; Chavez-Tapia NC; Franco-Guzman AM; Garcia-Saenz-de Sicilia M; Tellez-Avila FI Rev Gastroenterol Mex; 2008; 73(2):63-7. PubMed ID: 19666248 [TBL] [Abstract][Full Text] [Related]
24. Celiac plexus block for pancreatic cancer pain in adults. Arcidiacono PG; Calori G; Carrara S; McNicol ED; Testoni PA Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD007519. PubMed ID: 21412903 [TBL] [Abstract][Full Text] [Related]
25. Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial. Smit EF; Felip E; Uprety D; Nagasaka M; Nakagawa K; Paz-Ares Rodríguez L; Pacheco JM; Li BT; Planchard D; Baik C; Goto Y; Murakami H; Saltos A; Pereira K; Taguchi A; Cheng Y; Yan Q; Feng W; Tsuchihashi Z; Jänne PA Lancet Oncol; 2024 Apr; 25(4):439-454. PubMed ID: 38547891 [TBL] [Abstract][Full Text] [Related]
26. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. Ball D; Mai GT; Vinod S; Babington S; Ruben J; Kron T; Chesson B; Herschtal A; Vanevski M; Rezo A; Elder C; Skala M; Wirth A; Wheeler G; Lim A; Shaw M; Schofield P; Irving L; Solomon B; Lancet Oncol; 2019 Apr; 20(4):494-503. PubMed ID: 30770291 [TBL] [Abstract][Full Text] [Related]
27. Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study. Lakhani NJ; Chow LQM; Gainor JF; LoRusso P; Lee KW; Chung HC; Lee J; Bang YJ; Hodi FS; Kim WS; Santana-Davila R; Fanning P; Squifflet P; Jin F; Kuo TC; Wan HI; Pons J; Randolph SS; Messersmith WA Lancet Oncol; 2021 Dec; 22(12):1740-1751. PubMed ID: 34793719 [TBL] [Abstract][Full Text] [Related]
28. Contrast-enhanced ultrasound-guided celiac plexus neurolysis in patients with upper abdominal cancer pain: initial experience. Wang L; Lu M; Wu X; Cheng X; Li T; Jiang Z; Shen Y; Liu T; Ma Y Eur Radiol; 2020 Aug; 30(8):4514-4523. PubMed ID: 32211966 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of EUS-guided celiac plexus neurolysis in combination with EUS-guided celiac ganglia neurolysis for pancreatic cancer-associated pain: a multicenter prospective trial. Kamata K; Kinoshita M; Kinoshita I; Imai H; Ogura T; Matsumoto H; Minaga K; Chiba Y; Takenaka M; Kudo M; Kitano M Int J Clin Oncol; 2022 Jul; 27(7):1196-1201. PubMed ID: 35412211 [TBL] [Abstract][Full Text] [Related]
30. Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study. Xu J; Shen L; Bai C; Wang W; Li J; Yu X; Li Z; Li E; Yuan X; Chi Y; Yin Y; Lou W; Xu N; Bai Y; Zhang T; Xiu D; Wang X; Yuan Y; Chen J; Qin S; Jia R; Lu M; Cheng Y; Zhou Z; Li J; He J; Su W Lancet Oncol; 2020 Nov; 21(11):1489-1499. PubMed ID: 32966810 [TBL] [Abstract][Full Text] [Related]
31. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial. Kunzmann V; Siveke JT; Algül H; Goekkurt E; Siegler G; Martens U; Waldschmidt D; Pelzer U; Fuchs M; Kullmann F; Boeck S; Ettrich TJ; Held S; Keller R; Klein I; Germer CT; Stein H; Friess H; Bahra M; Jakobs R; Hartlapp I; Heinemann V; Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):128-138. PubMed ID: 33338442 [TBL] [Abstract][Full Text] [Related]
32. A prospective study of EUS-guided celiac plexus neurolysis for pancreatic cancer pain. Gunaratnam NT; Sarma AV; Norton ID; Wiersema MJ Gastrointest Endosc; 2001 Sep; 54(3):316-24. PubMed ID: 11522971 [TBL] [Abstract][Full Text] [Related]
33. Phenol-based endoscopic ultrasound-guided celiac plexus neurolysis for East Asian alcohol-intolerant upper gastrointestinal cancer patients: a pilot study. Ishiwatari H; Hayashi T; Yoshida M; Ono M; Masuko H; Sato T; Miyanishi K; Sato Y; Takimoto R; Kobune M; Miyamoto A; Sonoda T; Kato J World J Gastroenterol; 2014 Aug; 20(30):10512-7. PubMed ID: 25132769 [TBL] [Abstract][Full Text] [Related]
34. Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study. Philip PA; Lacy J; Portales F; Sobrero A; Pazo-Cid R; Manzano Mozo JL; Kim EJ; Dowden S; Zakari A; Borg C; Terrebonne E; Rivera F; Sastre J; Bathini V; López-Trabada D; Asselah J; Saif MW; Shiansong Li J; Ong TJ; Nydam T; Hammel P Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):285-294. PubMed ID: 31953079 [TBL] [Abstract][Full Text] [Related]
35. Effectiveness of Percutaneous Celiac Plexus Ablation in the Treatment of Severe Cancer Pain in Upper Abdomen and Evaluation of Health Economics. Cao J; He Y; Liu H; Wang S; Zhao B; Zheng X; Yang K; Xie D Am J Hosp Palliat Care; 2017 Mar; 34(2):142-147. PubMed ID: 26764345 [TBL] [Abstract][Full Text] [Related]
36. Low Volume Neurolytic Retrocrural Celiac Plexus Block for Visceral Cancer Pain: Retrospective Review of 507 Patients with Severe Malignancy Related Pain Due to Primary Abdominal Cancer or Metastatic Disease. Rahman A; Rahman R; Macrinici G; Li S Pain Physician; 2018 Sep; 21(5):497-504. PubMed ID: 30282394 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of neurolytic celiac plexus block in varying locations of pancreatic cancer: influence on pain relief. Rykowski JJ; Hilgier M Anesthesiology; 2000 Feb; 92(2):347-54. PubMed ID: 10691219 [TBL] [Abstract][Full Text] [Related]
38. Comparison Between Two Volumes of 70% Alcohol in Single Injection Ultrasound-Guided Celiac Plexus Neurolysis: A Randomized Controlled Trial. Abdel-Ghaffar ME; Ismail SA; Ismail RA; Abdelrahman MM; Abuelnaga ME Pain Physician; 2022 May; 25(3):293-303. PubMed ID: 35652769 [TBL] [Abstract][Full Text] [Related]
39. Increasing the efficacy of a celiac plexus block in patients with severe pancreatic cancer pain. Vranken JH; Zuurmond WW; de Lange JJ J Pain Symptom Manage; 2001 Nov; 22(5):966-77. PubMed ID: 11728800 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of outcomes of ultrasound guided celiac plexus neurolysis using immediate post procedure computed tomography: An observational study. Bhatnagar S; Thulkar S; Dhamija E; Khandelwal I; Nandi R; Chana G Indian J Gastroenterol; 2017 Jul; 36(4):282-288. PubMed ID: 28828591 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]